National Health Investors (NHI) Net Income towards Common Stockholders (2009 - 2026)

National Health Investors' Net Income towards Common Stockholders history runs 15 years deep, the most recent figure standing at $40.0 million for Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 17.33% year-over-year to $40.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $147.9 million (up 4.84% YoY) and the FY2025 annual result came in at $142.0 million, up 2.98% from the prior year.
• Net Income towards Common Stockholders was $40.0 million for Q1 2026 at National Health Investors, up from $38.1 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $43.2 million in Q4 2024 and bottomed at $1.9 million in Q4 2022.
• A 5-year average of $32.1 million and a median of $34.3 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Peak annual rise in Net Income towards Common Stockholders reached 1619.11% in 2023, while the deepest fall reached 14.92% in 2023.
• National Health Investors' Net Income towards Common Stockholders stood at $1.9 million in 2022, then surged by 1619.11% to $32.0 million in 2023, then jumped by 34.93% to $43.2 million in 2024, then declined by 11.8% to $38.1 million in 2025, then increased by 5.01% to $40.0 million in 2026.
• Business Quant data shows NHI's Net Income towards Common Stockholders at $40.0 million in Q1 2026, $38.1 million in Q4 2025, and $32.8 million in Q3 2025.